The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.
The Scientist
Most Recent
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
A US federal advisory committee finds that climate change is already impacting the country, and that it’s not about to stop.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
